drugset / Trial / NCT00782405

Effect of Quetiapine XR on Sleep in Patients With Major Depression, as Compared With Mirtazapine

NCT00782405

Phase 3 Completed 40 enrolled Technical University of Munich
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to examine the effects of (a) quetiapine XR and (b) mirtazapine on sleep when given as an antidepressant (monotherapy). We hypothesize that (a) quetiapine XR has an immediate and lasting positive effect on sleep in depressed patients which does not differ from the impact of mirtazapine on sleep in this group of patients; (b) in the context of a secondary objective, we expect an antidepressant effect of quetiapine XR which is equivalent to that of mirtazapine.

Timeline

Start
2008-10
Primary completion
2011-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mirtazapine Other / unclassified 30 mg
Comparator Mirtazapine Other / unclassified 45 mg
Subject Quetiapine Small molecule 150 mg
Subject Quetiapine Small molecule 300 mg

Indications

No indication recorded.